









































Senescence is an inevitable consequence of life. As a 
result of exposure to intrinsic- as well as extrinsic-aging 
factors, cellular aging is triggered by gradually accumu-
lating DNA damage and epigenetic changes [1]. Thus, 
aging can be envisioned, at the cellular level, as a result 
of altered cell function in response to changes in DNA 
structure that directly affects proper gene expression. 
Since stem cells (SCs) have more efficient mechanisms 
of DNA repair, these changes affect mainly already 
differentiated somatic cells. SCs, however, also age, and 
according to the best evidence, there is a gradual age-
related decrease in  their  self-renewal potential;   at  the 
 
 









































molecular level there are concomitant changes, such as 
the well-known phenomenon of telomere shortening 
[2]. 
 
Several well-known risk factors, such as obesity, 
diabetes, and lack of physical activity that lead to 
atherosclerosis of the cardio-vascular system and impair 
the function of vital organs (e,g., heart, kidney, or 
brain), limit overall life span. On the other hand, it is 
obvious that all these risk factors somehow must 
ultimately have an impact on the basic units of             
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these cells reside and thereby impair SC self renewal 
and differentiation. On the other hand, these risk 
factors may also lead to enhanced turn-over/ 
proliferation of SCs, resulting in premature exhaustion 
of these cells.  
 







small embryonic-like stem cells (VSELs) in adult 
murine tissues [3]. We envision that these pluripotent 
stem cells (PSCs) are deposited during early 
embryogenesis and reside in adult tissues as a backup 
for monopotent tissue-committed stem cells (TCSCs) 
that rejuvenate particular organs. Our data indicate that 
the pool of these cells decreases in adult murine tissues 
in an age-dependent manner [4]. We have also 
demonstrated that the proliferation and potentially 
premature depletion of these cells is negatively 
controlled by epigenetic changes of some imprinted 
genes  that  regulate  signaling  of  insulin  factors        
(Igf2-H19 locus, Igf2R and RasGRF1) [5]. Thus, these 
molecular data that link insulin/insulin growth       
factor-1 and -2 (Ins/Igf) signaling to the proliferation 
state of VSELs have implications for aging and 
senescence.  It is well known, for example, that the 
level of insulin-like growth factor-1 (Igf-1) in             
blood plasma negatively correlates with longevity [6]. 
In this review, based on our preliminary data, we 
postulate a novel link between plasma Igf-1    level, 
aging, and the pool of VSELs residing in adult tissues.   
 
We propose a novel hypothesis in which gradual 
decrease in the VSEL pool deposited in adult tissues 
due to chronic Ins/Igf signaling is an important 
mechanism of aging. We assume that an opposite 
beneficial effect on the size of the VSEL pool and     
life span would result from a decrease in stimulation 
by insulin factors. Our preliminary data in long-     
living Igf-1-signaling-deficient mice, which have a     
3–4 times higher number of VSELs in bone marrow 
(BM), lends support to this novel hypothesis. Thus, 
our data somewhat reconcile aging and longevity           
by showing that i) signaling by Ins/Igf and           
excessive caloric uptake are related and ii) both of 
these factors have a negative effect on the number         
of pluripotent VSELs residing in adult tissues. 
Depletion of these PSCs in an Ins/Igf-dependent 
manner may lead to a premature decrease in             
VSELs and the regenerative potential of mono-       
potent  tissue-committed  stem  cells  (TCSCs)           




Heterogeneity of the stem cell compartment 
 
Stem cells (SCs) possess the unique property of self 
renewal where, by symmetric division, they generate two 
daughter SCs and so maintain their number, and where, 
by asymmetric division, they give rise to one SC and one 
progenitor cell that will differentiate into somatic cells 
that are used up during life. However, clear evidence 
indicates that SCs are not all equal and form a hierarchy 
in their ability to specify into adult tissues [7]. While the 
most primitive SCs, the fertilized oocyte (zygote) or the 
first blastomers in the morula, are able to give rise to both 
embryo and placenta (totipotent SCs), cells isolated from 
the inner cell mass (ICM) of the blastocyst differentiate 
into embryonic tissues only (pluripotent SCs) [8].  
 
PSCs from the ICM of the blastocyst form first the 
epiblast, which subsequently gives rise to all three germ 
layers [8]. Thus, the epiblast is the source of PSCs, 
multipotent SCs (MSCs) giving rise to tissues form one 
of the germ layers, and finally, most differentiated 
TCSCs (monopotent SCs). TCSCs are already restricted 
in their differentiation potential to cells for one tissue 
only (e.g., epidermis, intestinal epithelium, liver, skeletal 
muscles, or lympho-hematopoiesis) and in adult 
organisms are usually identified in several characteristic 
tissue locations (e.g., in the basal layer of epidermis and 
hair budge [epidermis], the bottom of intestinal crypts 
[intestine], around Herring ducts [oval stem cells in 
liver], around muscle fibers [satellite stem cells in 
muscles], and in endosteal areas [bone marrow 
hematopoietic stem cells] ) [7].  
 
Looking at the hierarchy of the stem cell compartment 
and its developmental specification, an important 
question emerges. Is the differentiation of SCs a “one 
way street”, where during embryogenesis all PSCs 
gradually disappear, giving rise to TCSCs or, 
alternatively, do some epiblast-derived PSCs survive 
beyond embryonic development into adulthood and 
remain as a “hibernating" backup population for TCSCs? 
This possibility would somewhat mimic the organization 
of the stem cell compartment in urodeles, where a 
population of the precursors of pluripotent blastema SCs 
is left dormant during development in adult tissues [9]. 
 
Identification of VSELs in adult tissues lends support to 
this second possibility, that some PSCs may survive into 
adulthood as a backup for rejuvenation of TCSCs (Figure 
1). Thus, changes in the number of VSELs and their 
proliferative potential would directly impact aging/sense-
cence  and  longevity  by  affecting  the  pool  of  TCSCs.  
 
   














Very small embryonic-like stem cells (VSELs) from 
adult tissues     
 
We have purified VSELs by employing FACS-based 
multiparameter sorting, first from the murine BM and 
then for similar cells sorted from several other adult 
murine organs (i.e., brain, liver, skeletal muscles, heart, 
and kidney) [10]. Murine BM-derived VSELs: i) are 
very rare (~0.01% of nucleated BM cells); ii) are small 
in size (~3–5 μm); iii) express several PSC markers, 
such as Oct4, Nanog, Rex-1, and SSEA-1; iv) possess 
large nuclei containing unorganized chromatin 
(euchromatin); and v) are capable of differentiation into 
cells from all three germ lineages in vitro. Furthermore, 
VSELs exhibit a significantly higher nuclear/cytoplasm 
(N/C) ratio and a lower cytoplasmic area compared to 
HSCs. We recently confirmed the true expression of 
Oct4 and Nanog in BM-derived VSELs by 
demonstrating an unmethylated transcriptionally active 
open chromatin structure for both the Oct4 and Nanog 
promoters [5].  
 




– cells that display embryonic-like 
morphology have been identified by us in human 
umbilical cord blood (UCB), mobilized peripheral 
blood (mPB), and adult BM [11]. Human VSELs, 
similarly to their murine counterparts, contain large 
nuclei that, by transmission electron microscopy, show 
the presence of primitive unorganized euchromatin and 
a relatively small rim of cytoplasm containing 
numerous round mitochondria. They also express Oct4 
and Nanog within their nuclei and on their surface 
display the SSEA-4 antigen [11]. This suggests that a 
similar mechanism of tissue rejuvenation involving 
PSCs deposited in adult tissues also operates in humans. 
 
We postulate that VSELs are a population of highly 
migratory cells. To support this claim, we observed that 
the number of VSELs increases, both in mice and in 
humans, during stress situations related to tissue organ 
injuries (e.g., heart infarct, stroke, or acute colitis) as 
well as after administration of certain drugs that are 
employed on a routine basis in the clinic to mobilize 
hematopoietic stem progenitor cells (HSCs) into PB 
(i.e., G-CSF and AMD3100) [12-14]. The high motility 
of these cells further supports the concept that they play 
an important role in tissue/organ regeneration. 
 
Evidence for VSEL pluripotency 
 
Our data indicate that VSELs posses several 
morphological features of PSCs, such as a high 
Nuclear/Cytoplasmic ratio and the presence of 
unorganized euchromatin in nuclei. Below we will 
briefly discuss the most important other features of 
these cells that, based on their molecular analysis and in 
vitro and in vivo data, support their pluripotentiality.   
 
Molecular evidence. PSCs, according to their definition, 
should, at the molecular level, i) express acknowledged 
markers of pluripotency (e.g., Oct4 and Nanog), ii) 
possess bivalent domains in promoters of develop-
mentally crucial transcription factors (TFs), and iii) 
reactivate the X chromosome (in female PSCs), which 
becomes silenced at early stages of embryogenesis [15-
16].  
 
To support the notion that VSELs are pluripotent, our 
recent research has demonstrated that VSELs, not only 
express the transcription factor Oct4 (which is a 
characteristic marker of PSCs) at the mRNA and protein 
levels, but, as mentioned above, the Oct4 promoter in 
VSELs is in an active/open state [5]. Furthermore, our 
data indicate that murine VSELs display bivalent 
domains in promoters of several homeodomain-
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Figure  1.  Potential  VSEL  contribution  to  tissue 
rejuvenation.  VSELs  deposited  in  adult  tissues  during 
embryogenesis/gastrulation  may  become  eliminated  after 
giving  rise  to  TCSCs.  Conversely,  they  may  survive  among 
TCSCs  and  serve  as  a  potential  backup/reserve  source  of 
TCSCs.  Under  homoestatic  conditions,  primitive  VSELs 
should be protected from unleashing their own proliferation. 
   
www.impactaging.com                    877                                 AGING,   November 2010, Vol.2 No.11containing developmental TFs (ie.g., Sox21, Nkx2.2, 
Dlx1, Lbx14, Hlx9, and Pax5). The presence of 
transcriptionally active histone codes, such as 
H3K4me3, physically coexisting with repressive histone 
codes, such as H3K27me3, was confirmed by 
employing the carrier CHIP assay (submitted for 
publication). Finally, studies on female murine VSELs 
show that these cells partially re-activate the inactivated 
X chromosome. Thus, VSELs possess several molecular 
features expected from PSCs.  
 
In vitro evidence.  PSCs, according to their definition, 
should also differentiate into cells from all three germ 
layers (endo-, meso- and ectoderm) in vitro [7]. To 
support the concept of pluripotentiality of VSELs in 
vitro, we have also successfully developed several co-
culture condi-tions where VSELs, if plated over 
supportive cell lines, may expand/differentiate into a 
variety of somatic cell types [17]. One of these is a co-
culture system over OP9 stromal cells that allows 
hematopoietic specification of VSELs [18]. Another is a 
co-culture of VSELs over the myoblastic cell line 
C2C12, which allows some VSELs to differentiate and 
form spherical structures that resemble embryoid bodies 
and stain positively for the fetal isoform of alkaline 
phosphatase [19]. More importantly, cells isolated from 
these murine VSEL-derived spheres, if plated into 
cultures promoting tissue differentiation, expand into 
cells from all three germ-cell layers [3]. Interestingly, 
the formation of spheres by VSELs was associated with 
a young age in mice, and no sphere formation was 
observed with cells isolated from older mice (>2 years 
old). Unfortunately, we have so far not been able to 
reproduce this phenomenon using human VSELs, which 
suggests the involvement of murine cell-specific 
factors. In summary, while VSELs do not display all the 
molecular markers characteristic of PSCs, they are able 
to differentiate into cells from all three germ layers in 
vitro.  
 
In vivo evidence.  Our recent collaborative work in vivo 
indicates that VSELs may also be specified in vivo into 
MSCs [20] and cardiomyocytes [21-22]. Accordingly, 
in the first study by Taichman et al, VSELs isolated 
from GFP
+ mice were implanted into SCID mice and 4 
weeks later the formation of bone-like tissues was 
observed. To further validate that VSELs exhibit true 
MSC activity (bone formation), stromal cells were 
harvested from Col2.3∆TK mice and implanted into 
SCID mice to generate thymidine kinase-sensitive 
ossicles. At 1.5 months, the ossicles were injected with 
2000 GFP
+ VSELs. At harvest, there was observed to   
be  a  co-localization  of  GFP-expressing  cells  with             
an  antibody to  the osteoblast-specific  marker  Runx-2,  
the endothelial marker CD31, and the adipocyte marker 
PPARγ. Based upon the ability of uncultured VSELs to 
(i) differentiate in vivo into mutiple mesenchymal 
lineages and (ii) to generate osseous tissues at low 
density, Taichman et al. proposed that this population of 
cells fulfills many of the required characteristics of 
MSCs [20]. 
 
In another collaborative study, BM-derived VSELs 
freshly isolated from GFP
+ mice were injected into the 
hearts of mice that had undergone ischemia/reper- 
fusion injury [21]. After 35 days of follow-up,           
VSEL-treated mice exhibited improved global and 
regional left ventricular  (LV)  systolic  function           
(by echocardio-graphy) and attenuated myocyte 
hypertrophy  (by  histology  and  echocardiography)        
in surviving tissue when compared with vehicle-     
treated controls. Since VSELs isolated from GFP
+ 
transgenic mice were employed for transplantation,       
we could track the fate of injected cells in the 
myocardium. Although VSEL transplantation resulted 
in isolated new myocytes and capillaries in the           
infarct region, their numbers were too small to account 
for all of the observed benefits [22]. Thus, it is likely 
that, in this particular tissue injury model, some 
paracrine effects by transplanted VSELs played an 
additionally important role and we are now analyzing 
the profile of growth factors and cytokines secreted by 
these cells.  
 
However, unlike PSCs from established embryonic 
stem cell lines, VSELs neither complete blastocyst 
development after injection into the developing 
blastocyst nor form teratomas after injection into 
immunodeficient mice. The explanation for this is, as 
we have  reported, epigenetic modification of crucial 
imprinted genes, from which some (i.e., Igf2 and 
RasGRF1) are important for senescence and longevity 
[5]. This will be discussed in more details in the 
following paragraph.    
 
Epigenetic changes in imprinted genes related to insulin 
factor signalin keep VSELs quiescent in adult tissues. 
It is well known that changes in Ins/Igf signaling have 
important implications for aging. Accordingly, i) Igf-1 
signaling  negatively  regulates  lifespan  in  worms,     
flies, and mammals [23] and ii) Igf-1 and insulin         
level in blood is regulated positively by caloric uptake 
[24].  
 
What is crucial for our hypothesis and is the main topic 
of this review is that we have recently identified an 
important epigenetic mechanism that governs the   
VSEL quiescent state, preventing them from unleashing  
 
   












































proliferation and the spontaneous growth of teratomas 
[5]. This mechanism is based on the epigenetic changes 
in selected somatic-imprinted genes (i.e., Igf2-H19, 
Ig2R, and RasGRF1) that are involved in insulin factor 
signaling (Igf-1, Igf-2, and Insulin) (Figure 2).  
 
Accordingly, VSELs downregulate expression of Igf2 
that, at the embryonic stage of development, is an 
autocrine growth factor for these cells, and in addition, 














































cular sink for Igf2 [25]. In contrast Igf2 may signal by 
binding to Igf-1R. Additionally, Ins/Igf signaling is 
impaired due to erasure of the imprint on RasGRF1, 
which is a small GTP exchange factor (GEF) for both 
Igf-1R and the insulin receptor (InsR) [26]. The 
involvement of these genes in signaling from activated 
insulin factor receptors is depicted schematically in 
Figure 3. Thus, as we believe, impaired signaling from 
Igf-1R and InsR is responsible for keeping these cells 
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www.impactaging.com                    879                                  AGING,    November 2010, Vol.2 No.11chronic stimulation over time with insulin and Igf-1 
could lead to accelerated depletion of these cells. Since 
the number of VSELs decreases with age in mice and 
correlates with their senescence, this could explain the 
aging process at the level of the PSCs that are deposited 
in adult tissues during development (VSELs) [4]. A 
decrease in these cells will impair the regenerative 
function of their progeny - the pool of TCSCs.     
 
In fact, our studies performed on normal young (4-
week-old) and old (2-year-old) mice revealed that the 












































during ageing. Accordingly, VSELs from old mice 
show lower expression of the pluripotentiality master-
regulators such as Oct4, Nanog, Sox2, Klf4, and cMyc 
and, at the molecular level, the Oct4 promoter in VSELs 
becomes hypermethylated with age and shows a closed 
chromatin structure. Furthermore, VSELs from old mice 
show the somatic type of methylation at both Igf2-H19 
and RasGRF1 loci, which suggests that VSELs from old 
mice have increased sensitivity to insulin factor 
signaling. This suggests that chronic Ins/Igf signaling   
in VSELs may contribute to, age-related depletion of   













































CELL PROLIFERATION METAOBOLICFUNCTIONS CELL PROLIFERATION METABOLIC FUNCTIONS
Figure 3. Insulin/Igf signaling and imprinted genes. In mammals there are three insulin factors (Insulin, Igf‐1, 
and Igf2) that bind to two tyrosine kinase receptors, insulin receptor (InsR) and Igf‐1 receptor (Igf‐1R). Igf2R is a non‐









































Lessons from Laron dwarf mice 
 
To test the hypothesis that chronic Ins/Igf signaling may 
accelerate depletion of the pool of VSELs in adult 
tissues, we became interested in Laron dwarf mice. Due 
to a deficiency of growth hormone (GH) receptor, these 
animals display a severe reduction in the Igf-1 plasma 
level and do not display increase in GH-mediated Igf-1 
plasma level in response to caloric uptake [27]. 
Interestingly, these animals live 30–40% longer than 
their normal littermates [28]. Several possible 
explanations for this effect have been proposed, but we 
became interested in whether a reduced level of Igf-1 in 
the plasma of these animals may directly impact the 
survival of VSELs in adult murine tissues.  
 
Thus, to explain better the role of Igf-1 signaling in 
VSELs, we measured the number of VSELs in BM of 
murine Laron dwarfs by FACS. Interestingly, we 
noticed that the number of VSELs in the BM of plasma 



































higher level than normal wild type littermates during 
aging. Our molecular analysis studies have additionally 
demonstrated that the Oct4 promoter in these animals 
shows also a higher level of demethylation [29].  
 
Furthermore, while analysis of PB cell counts did not 
reveal any differences in the number of erythrocytes, 
platelets, and leucocytes between Laron dwarf mice and 
wild type controls, we observed that Laron dwarf mice 




– (SKL) hematopoietic stem cells 
and ii) a >4-fold higher number of clonogenic CFU-
Mix, CFU-GM, BFU-E, and CFU-Meg cells.   
 
Since the plasma Igf-1 level is regulated in mice by 
caloric uptake and in humans by calorie uptake if in 
particular protein content in the diet is low [30], these 
data shed new light on caloric restriction, senescence, 
and the size of hematopoietic stem cell compartment. 
Based on this, we propose a new paradigm in which 
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situation seen in chronic caloric restriction in mice, 
where the Igf-1 level is low and results in longevity. 
Since the long-living Laron dwarf mice that maintain 
low levels of Igf-1 have higher numbers of VSELs and 
HSCs in BM, we postulate that chronically elevated 
levels of Igf-1, resulting, for example, from high caloric 
uptake, may lead to premature depletion of the stem cell 
pool, including VSELs and HSCs, and thus be 
responsible for premature aging in mice. This 
hypothesis is currently being tested in mice that 
overexpress GH and thus have high plasma Igf-1 level, 
and, interestingly, in contrast to Igf-1–deficient Laron 
dwarf mice, show a much shorter life span. 
 
Further studies are also needed to link the effect of 
chronic high Igf-1 signaling in VSELs with the 
development of cancer. Of note, both murine Laron 
dwarfs [28] and human Laron dwarfs [31] with 
chronically low Igf-1 levels are significantly protected 
from developing cancer [28,31]. Since many human 
malignancies are activated by Igf -1 and Igf-2 signaling 
(e.g., due to loss of heterozygosity or loss of imprinting 
at the Igf-2-H19 locus) [32], we hypothesize that 
excessive activation of VSELs in an Ins/Igf-dependent 
manner could promote malignant transformation of 
these cells. However, the hypothetical reverse effect of 
low Ins/Igf signaling on a pool of VSELs that could 





Aging-associated changes in the nuclear architecture, 
chromatin structure, altered expression and activity of 
chromatin remodeling factors, and the change in pattern 
of epigenetic marks (DNA methylation and histone 
modification) affect all cells in the adult body, including 
the population of SCs that is responsible for proper 
tissue rejuvenation [34]. The elucidation of these 
precise mechanisms will help to develop more efficient 
anti-aging strategies as well as facilitate a better 
understanding of age-related risks for cancer genesis. 
 
Based on our data, we postulate novel linkages between 
the Igf-1 level, aging, and the stem cell compartment. 
According to our hypothesis, early in development a 
population of VSELs would be deposited in developing 
organs as a backup for tissue-committed stem cells that 
plays a role in rejuvenation of tissues and organ 
regeneration after damage [7]. These cells seem to be 
protected from uncontrolled proliferation and age-
related depletion by changes in imprinted genes that 
regulate insulin signaling [5]. We hypothesize that the 
pool of VSELs residing in adult tissues is regulated by 
the circulating Igf-1 level. An increase in Igf-1 level 
(e.g., resulting from a chronically high caloric uptake) 
would accelerate in an Ins/Igf -dependent manner an 
age-dependent depletion of the pool of VSELs and their 
potential to rejuvenate tissues. By contrast, a low Igf-1 
level (e.g., as seen in Laron dwarf mutants or as a result 
of caloric restriction) would have an opposite and 
protective effect on these cells.  
 
Thus, we present for the first time a hypothesis that 
reconciles aging, longevity, insulin factor signaling, and 
high caloric uptake with the abundance and function of 
pluripotent VSELs deposited in adult tissues. A 
decrease in the number of these cells will affect pools of 
TCSCs and have an impact on tissue rejuvenation and 
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